March 21, 2008 -- Shanghai GenePharma Co., Ltd. signed a non-exclusive worldwide license to use the Kreutzer-Limmer siRNA patents belonging to Alnylam Pharmaceuticals (NSDQ: ALNY). The license, which is the first transaction Alnylam has signed with a China biotech, covers the right to manufacture and provide RNAi research products and services. GenePharma will manufacture RNAi reagent products for research use in China and worldwide. More details...
